Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gliosarcoma × peposertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Solid Tumor, Adult 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphatic Metastasis 1 Gliosarcoma 1 Glioblastoma 1

Interventions

Temozolomide 3 Specimen Handling 2 Radiotherapy 2 peposertib 1 pembrolizumab 1 gosha-jinki-gan 1 efineptakin alfa 1 cabozantinib 1 atezolizumab 1 abexinostat 1 Radiation 1 ONC206 1 Ipilimumab 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04555577 2025-10-29

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

M.D. Anderson Cancer Center

Phase 1 Recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡